Africa's Cancer Research Company


We use cutting edge immunogenomics, bioinformatics and artificial intelligence to accelerate the development of cancer detection and cure strategies, ultimately with the goal of lowering the economic burden of cancer on the African continent.


Learn More
 

What We Do

We are focused on improving cancer care through greater understanding of human genetic diversity.

About Us

Our Mission

Our mission is to redefine how cancer is diagnosed and treated in Africa, through innovative, sustainable biomedical research and partnerships that aid in the advancement of medicine across the continent. This includes:

  • Optimise existing molecular diagnostic and prognostic tests for African populations and provide these as part of screening service.
  • Identify novel biomarkers for early detection of cancer among African populations and develop novel diagnostic tools based on these markers
  • Engage with local community to promote cancer awareness, stressing the importance of early detection and providing education on the utility of molecular (genomic) techniques in aiding in the diagnosis and prognosis of cancer.
  • Accelerate adoption of personalised medicine among African population.
 

News


May 25, 2022

Ghana startup strives for greater African representation in cancer research

As one of Ghana's only labs equipped for molecular analysis, Bediako's team have tasked themselves with collecting data they believe will advance the development of medicine for cancer patients throughout the continent and diaspora
March 21, 2022

Yemaachi, Africa’s Cancer Research Company, Raises Seed Round To Diversify Genomic Datasets & Advance Precision Oncology Globally

Yemaachi Biotech announced today the close of a $3 million seed round to advance its mission of diversifying precision oncology globally. V8 Capital led the round, with LifeLine Family Heritage Fund, Y Combinator, Tencent, LoftyInc Capital, VestedWorld, V Square Capital and Ethan Perlstein also participating.
February 22, 2022

Yemaachi Launches HPV Molecular Test in Ghana for At-Home Cervical Cancer Risk Assessment

GenomeWeb covers Yemaachi's launch of its Sheba HPV Test, a convenient discreet way for women to screen themselves for HPV and assess their risk for cervical cancer.
 

Contact details

Do you have any questions about our services?

222 Swaniker Street,
Abelempke, Accra,
Ghana


+233 (0)502 528 528
info@yemaachi.com